3,4-dihydroxyphenylacetic acid has been researched along with Kidney Failure, Chronic in 2 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hypertensive patients with chronic renal failure shared with their hypertensive counterparts without chronic renal failure an impaired DOPA decarboxylation to dopamine." | 1.29 | Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency. ( Kuchel, OG; Shigetomi, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuchel, OG | 1 |
| Shigetomi, S | 1 |
| Nakayama, H | 1 |
| Inagaki, M | 1 |
| Ito, S | 1 |
| Gotoh, Y | 1 |
| Oguchi, K | 1 |
2 other studies available for 3,4-dihydroxyphenylacetic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
Topics: 3,4-Dihydroxyphenylacetic Acid; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Diastole; Dih | 1994 |
Measurement of catecholamine metabolites: assessment of autonomic impairment in diabetic patients treated by hemodialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Diabetic Neuropathies; Dopamine; | 2000 |